Allergy Therapeutics plc (AGY.L)

GBp 6.4

(-0.78%)

Long Term Debt Summary of Allergy Therapeutics plc

  • Allergy Therapeutics plc's latest annual long term debt in 2022 was 26.43 Million GBP , up 1666.13% from previous year.
  • Allergy Therapeutics plc's latest quarterly long term debt in 2023 Q2 was 948 Thousand GBP , down 0.0% from previous quarter.
  • Allergy Therapeutics plc reported annual long term debt of 1.49 Million GBP in 2021, down -38.9% from previous year.
  • Allergy Therapeutics plc reported annual long term debt of 2.45 Million GBP in 2020, down -16.3% from previous year.
  • Allergy Therapeutics plc reported quarterly long term debt of 26.43 Million GBP for 2022 FY, up 1666.13% from previous quarter.
  • Allergy Therapeutics plc reported quarterly long term debt of 26.43 Million GBP for 2022 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Allergy Therapeutics plc (2022 - 2001)

Historical Annual Long Term Debt of Allergy Therapeutics plc (2022 - 2001)

Year Long Term Debt Long Term Debt Growth
2022 26.43 Million GBP 1666.13%
2021 1.49 Million GBP -38.9%
2020 2.45 Million GBP -16.3%
2019 2.92 Million GBP 68.03%
2018 1.74 Million GBP -27.84%
2017 2.41 Million GBP -17.78%
2016 2.93 Million GBP -4.36%
2015 3.07 Million GBP 114.24%
2014 1.43 Million GBP 0.0%
2013 - GBP 0.0%
2012 - GBP -100.0%
2011 97 Thousand GBP -99.22%
2010 12.36 Million GBP 16.66%
2009 10.59 Million GBP -44.97%
2008 19.25 Million GBP -17.76%
2007 23.41 Million GBP 983.43%
2006 2.16 Million GBP 0.0%
2005 - GBP -100.0%
2004 455 Thousand GBP -48.35%
2003 881 Thousand GBP -45.11%
2002 1.6 Million GBP -82.19%
2001 9.01 Million GBP 0.0%

Peer Long Term Debt Comparison of Allergy Therapeutics plc

Name Long Term Debt Long Term Debt Difference